V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240011385 | 240007581 | 1.8 | 67.9 | Palliative (P) | 2016-07-23 | 2017-02-08 | Bevacizumab | N | N | 240029939 | BEVACIZUMAB |
| 240011386 | 240007582 | 1.68 | 36.8 | null | null | 2017-03-01 | Methotrexate intrathecal | N | null | 240029940 | METHOTREXATE INTRATHECAL |
| 240011387 | 240007586 | 1.5 | 72.5 | Palliative (P) | 2015-02-16 | 2015-04-16 | ALCL ALCL 99 Closed AM 1, 2 or 3 | N | N | 240029942 | NOT MATCHED |
| 240011388 | 240007589 | 1.58 | null | Not known (9) | 2016-07-02 | 2016-07-08 | Bevacizumab 15mg/kg | N | N | 240029953 | BEVACIZUMAB |
| 240011389 | 240007590 | 1.73 | 62.8 | Curative (C) | null | 2017-01-19 | INTERLACE TRIAL | N | N | 240029957 | INTERLACE TRIAL |
| 240011390 | 240007592 | 1.7 | 72.5 | Curative (C) | 2014-02-02 | 2014-03-24 | HD EuroNet-PHL-C1 Relapsed BEAM | N | null | 240029957 | NOT MATCHED |
| 240011391 | 240007593 | 1.68 | 93.8 | Curative (C) | 2018-01-22 | 2018-07-09 | Trial Unspecified | Y | Y | 240029973 | TRIAL |
| 240011392 | 240012082 | 1.54 | 90.7 | Curative (C) | 2016-12-22 | 2016-12-24 | Trial Unspecified | N | N | 240029974 | TRIAL |
| 240011393 | 240007597 | 1.06 | 51 | Disease modification (D) | 2015-09-05 | 2016-02-23 | Trial Unspecified | N | N | 240029975 | TRIAL |
| 240011394 | 240007598 | 1.64 | 50.4 | null | 2017-09-28 | 2017-09-28 | Trial Unspecified | 2 | N | 240029975 | TRIAL |
| 240011395 | 240012084 | 1.6 | 115.9 | Palliative (P) | 2017-01-26 | 2017-02-26 | Trial Unspecified | null | Y | 240029988 | TRIAL |
| 240011396 | 240012084 | 1.83 | 67.9 | Neo-adjuvant (N) | 2013-11-13 | 2014-09-16 | null | 02 | Y | 240029988 | NOT MATCHED |
| 240011397 | 240007600 | 1.68 | 0 | Adjuvant (A) | 2013-04-15 | 2013-10-04 | CHOP | N | N | 240030003 | CHOP |
| 240011398 | 240007602 | 1.6 | 81.3 | Palliative (P) | null | 2017-10-21 | Bevacizumab+Carbo+Pacliaxel | 1 | N | 240030010 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240011399 | 240007605 | null | 81.9 | null | 2017-11-15 | 2017-11-19 | BEVACIZUMAB + CARBO + PACLITAXEL | null | null | 240030010 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240011400 | 240016242 | 1.74 | null | null | null | 2018-01-16 | ALCL ALCL 99 Closed AM 1, 2 or 3 | null | null | 240030024 | NOT MATCHED |
| 240011401 | 240007606 | 1.8 | 29.9 | Curative (C) | 2013-01-14 | 2013-03-17 | INTERLACE TRIAL | 2 | N | 240030035 | INTERLACE TRIAL |
| 240011402 | 240007609 | 1.66 | 65 | Adjuvant (A) | 2018-06-04 | 2018-07-03 | Trial Unspecified | 1 | N | 240030036 | TRIAL |
| 240011403 | 240007609 | 1.7 | 115.9 | null | 2014-08-05 | 2014-08-21 | CHOP - 21 days | 2 | N | 240030036 | CHOP |
| 240011404 | 240007609 | 1.67 | 41.8 | Palliative (P) | 2015-01-19 | 2015-02-09 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | N | 240030036 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240011405 | 240007610 | null | 19.4 | Curative (C) | 2013-09-17 | 2013-10-09 | ALCL ALCL 99 Closed BM 1, 2 or 3 | 2 | N | 240030063 | NOT MATCHED |
| 240011406 | 240007613 | 1.7 | 50.3 | Palliative (P) | null | 2017-09-25 | BEVACIZUMAB + CARBO + PACLITAXEL | N | null | 240030073 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240011407 | 240012089 | 1.69 | 65.6 | Palliative (P) | 2018-12-25 | 2018-12-25 | PACLITAXEL | Y | N | 240030075 | PACLITAXEL |
| 240011408 | 240012089 | 1.66 | 88 | Curative (C) | 2017-11-27 | 2017-12-13 | SMILE | N | N | 240030075 | TRIAL |
| 240011409 | 240012089 | null | null | Disease modification (D) | 2014-07-08 | 2014-07-08 | Azacitidine | 2 | N | 240030075 | AZACITIDINE |
| 240011410 | 240007619 | 1.55 | 54 | Disease modification (D) | 2014-05-15 | 2014-11-03 | INTERLACE TRIAL | null | null | 240030082 | INTERLACE TRIAL |
| 240011411 | 240007621 | 0 | 84.6 | Palliative (P) | 2017-04-16 | 2017-06-12 | Bevacizumab+Carbo+Pacliaxel | Y | N | 240030083 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240011412 | 240007622 | 1.89 | 102.1 | Curative (C) | 2016-04-15 | 2016-06-18 | Trial Unspecified | N | N | 240030093 | TRIAL |
| 240011413 | 240012092 | 0 | 61.3 | Palliative (P) | 2014-01-20 | 2014-02-05 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 240030103 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240011414 | 240007625 | 1.58 | 74.4 | Palliative (P) | 2014-10-05 | 2014-11-02 | Bevacizumab | Y | N | 240030106 | BEVACIZUMAB |
| 240011415 | 240007626 | 1.72 | null | Curative (C) | null | 2016-05-31 | BEVACIZUMAB + CARBO + PACLITAXEL | Y | N | 240030106 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240011416 | 240007627 | 1.6 | null | Curative (C) | 2015-06-15 | 2015-06-18 | Azacitidine | null | Y | 240030113 | AZACITIDINE |
| 240011417 | 240007627 | 1.58 | 21.6 | Curative (C) | 2017-04-17 | 2017-04-19 | Azacitidine | N | N | 240030113 | AZACITIDINE |
| 240011418 | 240007627 | 1.74 | 41.8 | Palliative (P) | 2016-02-16 | 2016-02-18 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 240030113 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240011419 | 240007629 | null | null | Curative (C) | 2015-10-28 | 2015-12-02 | Trial Unspecified | 02 | N | 240030150 | TRIAL |
| 240011420 | 240007630 | 1.66 | 67.2 | Palliative (P) | 2014-02-28 | 2014-03-12 | Azacitidine | Y | N | 240030150 | AZACITIDINE |
| 240011421 | 240014195 | null | 55.5 | Curative (C) | 2015-04-10 | 2015-04-24 | INTERLACE TRIAL | 02 | N | 240030171 | INTERLACE TRIAL |
| 240011422 | 240014195 | 1.91 | 97.8 | Palliative (P) | 2015-12-18 | 2015-12-18 | Trial Unspecified | 02 | N | 240030171 | TRIAL |
| 240011423 | 240015808 | 1.9 | 64.2 | Curative (C) | 2014-08-12 | 2014-08-20 | Amsacrine + BUSULFAN + CYTARABINE + FLUDARABINE | 02 | Y | 240030176 | NOT MATCHED |
| 240011424 | 240007631 | 0 | 34.7 | Curative (C) | 2014-05-05 | 2014-05-25 | Azacitidine | N | N | 240030190 | AZACITIDINE |
| 240011425 | 240007632 | 1.75 | null | null | 2013-07-04 | 2013-07-10 | Paclitaxel 80mg/m2 day 1 8 15 | 2 | N | 240030197 | PACLITAXEL |
| 240011426 | 240007632 | 1.67 | 102.5 | Curative (C) | 2016-02-01 | 2016-02-09 | INTERLACE TRIAL | N | N | 240030197 | INTERLACE TRIAL |
| 240011427 | 240007636 | 1.68 | 67.9 | Curative (C) | 2017-10-28 | 2017-12-10 | Trial Unspecified | null | null | 240030210 | TRIAL |
| 240011428 | 240007637 | 1.8 | 97.8 | Curative (C) | 2013-07-20 | 2013-09-05 | INTERLACE TRIAL | Y | null | 240030216 | INTERLACE TRIAL |
| 240011429 | 240007637 | 0 | null | Disease modification (D) | 2015-05-02 | 2015-05-03 | Azacitidine | N | N | 240030216 | AZACITIDINE |
| 240011430 | 240015809 | 1.62 | 70.6 | Curative (C) | 2015-02-01 | 2015-03-02 | ALCL ALCL 99 Closed AM 1, 2 or 3 | Y | N | 240030232 | NOT MATCHED |
| 240011431 | 240015809 | 1.06 | 117 | Palliative (P) | 2014-04-06 | 2014-09-19 | Bevacizumab | 2 | N | 240030232 | BEVACIZUMAB |
| 240011432 | 240015809 | 0 | 90.2 | Curative (C) | 2013-09-01 | 2013-09-08 | Azacitidine | N | N | 240030232 | AZACITIDINE |
| 240011433 | 240007638 | 1.71 | 142.7 | Disease modification (D) | 2014-11-14 | 2014-11-25 | Methotrexate intrathecal | 02 | N | 240030241 | METHOTREXATE INTRATHECAL |
| 240011434 | 240014197 | null | 47.9 | null | 2018-07-20 | 2018-07-22 | Bevacizumab+Carbo+Pacliaxel | 02 | N | 240030247 | BEVACIZUMAB + CARBO + PACLITAXEL |